ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Hamza Hashmi

0 views

July 1, 2024

Comments 1

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

2024 ASCO® Annual Meeting Insights Hub: Summaries & Highlights Videos

17:22

2024 ASCO® Annual Meeting Insights Hub

Highlights of Recent Updates in Myeloma: Part 2 - R/R Treatment

Feat. A. Jakubowiak

19:20

2024 ASCO® Annual Meeting Insights Hub

Highlights of Recent Updates in Myeloma: Part 1 - Frontline Treatment

Feat. A. Jakubowiak

21:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

Feat. E. Efstathiou

View All

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale

17:52

Indy Hematology Review

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Feat. K. Anderson

16:42

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…

Feat. H. Hashmi

17:46

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies …

Feat. A. Jakubowiak

07:11

GRACE

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve

19:08

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee

19:24

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…

Feat. P. Richardson

24:23

MyCancerHaven

Will CAR-Ts and Bispecifics Will Replace HSCT in Myeloma?

Feat. R. Vij, S. Al Hadidi

28:20

Indy Hematology Review

Managing Newly Diagnosed MM in 2024

Feat. S. Usmani

24:44

Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

13:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?…

Feat. O. Landgren

09:51

i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje

13:47

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maint…

Feat. B. Derman

05:35

Saurabh Chhabra

Bispecifics & CAR-Ts in MM: How to Choose and How to Sequence

20:19

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …

Feat. A. Paulus

20:18

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale

36:10

Insights from 2024 EHA Annual Meeting

Highlights in Plasma Cell Disorders From ASCO® and EHA

Feat. S. Al Hadidi

12:38

SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…

Feat. S. Usmani

35:37

University of Colorado Division of Hematology

2024 Updates on Multiple Myeloma Treatment

Feat. D. Sherbenou

26:46

Samer Al Hadidi

Login

Login

Join VuMedi

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"

2024 ASCO® Annual Meeting Insights Hub: Summaries & Highlights Videos

Recommended